Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated with anti-tumor necrosis factor (TNF)-alpha medication: a case report

被引：0

作者：

Selim Nalbant

Mustafa Özyurt

Murat Yıldırım

Mesih Kuskucu

机构：

[1] Maltepe University Medical School,Department of Internal Medicine

[2] Gulhane Military Medical Academy,Department of Microbiology

[3] Haydarpasa Training Hospital,Department of Internal Medicine

[4] Gulhane Military Medical Academy,Department of Orthopedic Surgery

[5] Haydarpasa Training Hospital,undefined

[6] Gulhane Military Medical Academy,undefined

[7] Haydarpasa Training Hospital,undefined

来源：

Rheumatology International | 2012年 / 32卷

关键词：

Rheumatoid arthritis; Anti-TNF agents; Knee joint; Tuberculosis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Tuberculosis infection (TB) is one of the most important problems for the rheumatoid arthritis (RA) patients treated with anti-TNF agents. Pulmonary tuberculosis is the most common clinic form of the TB in these patients. However, tuberculosis arthritis is very rare. We present here a 72-year-old Caucasian woman with seropositive RA, treated with etanercept/adalimumab for the last 2 years, who presented with resistant knee pain and joint effusion. We believe that this treatment caused the tuberculosis in this patient, which is the most worried complication. Interestingly, tuberculosis was in the knee joint at this time.

引用

页码：2863 / 2866

页数：3

共 50 条

[1] Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated with anti-tumor necrosis factor (TNF)-alpha medication: a case report
Nalbant, Selim
Ozyurt, Mustafa
Yildirim, Murat
Kuskucu, Mesih
[J]. RHEUMATOLOGY INTERNATIONAL, 2012, 32 (09) : 2863 - 2866
[2] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
Feldmann, M
Elliott, MJ
Woody, JN
Maini, RN
[J]. ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
[3] Weight Gain in Seropositive Rheumatoid Arthritis Patients Treated With Anti-tumor Necrosis Factor (TNF) Therapy
Alsulaim, Toka M.
Almulla, Maryah H.
Alotaibi, Najla S.
AlQudari, Elham A.
Alzahrani, Khalid A.
Nori, Rawad M.
Makkawy, Mosaab A.
Alhamzi, Hanan A.
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
[4] Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor
Hamann, Philip
Holland, Richard
Hyrich, Kimme
Pauling, John D.
Shaddick, Gavin
Nightingale, Alison
McHugh, Neil
[J]. ARTHRITIS CARE & RESEARCH, 2017, 69 (06) : 783 - 793
[5] Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis
Daniel, Rodney S.
Bourne, Rae L.
Simpson, Annie N.
O'Rourke, Kenneth S.
Bolster, Marcy B.
[J]. AMERICAN JOURNAL OF PHARMACY BENEFITS, 2009, 1 (02) : 81 - 89
[6] Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis
Haerter, G
Manfras, BJ
de Jong-Hesse, Y
Wilts, H
Mertens, T
Kern, P
Schmitt, M
[J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (09) : E88 - E94
[7] Two episodes of digital vasculitis in a patient with rheumatoid arthritis (RA) treated with anti-tumor necrosis factor-α (TNF-α): case report
Mohammad, Aladdin
Noltorp, Sven
[J]. APMIS, 2009, 117 : 110 - 110
[8] The effect of anti-tumor necrosis factor (TNF)-alpha therapy with etanercept on endothelial functions in patients with rheumatoid arthritis
Tikiz, Hakan
Arslan, Oezlem
Pirildar, Timur
Tikiz, Canan
Bayindir, Petek
[J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2010, 10 (02): : 98 - 103
[9] Anti-tumor necrosis factor α switching in rheumatoid arthritis and juvenile chronic arthritis
Favalli, EG
Arreghini, M
Arnoldi, C
Panni, B
Marchesoni, A
Tosi, S
Pontikaki, I
[J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02): : 301 - 302
[10] Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action
Feldmann, M
Brennan, F
Paleolog, E
Taylor, P
Maini, RN
[J]. EUROPEAN CYTOKINE NETWORK, 1997, 8 (03) : 297 - 300

← 1 2 3 4 5 →